Debbie's Place

A Patient's Point of View

BOWEL DISORDERS – also see GERD, COLITIS, IBS, CROHN’S

BOWEL DISORDERS – also see GERD, COLITIS, IBS, CROHN’S

 

Effects of cannabidiol derivatives on intestinal motility                    (abst – undated)

http://www.docstoc.com/docs/26071658/Effects-of-cannabidiol-derivatives-on-intestinal-motility-

 

Some actions of delta-1 tetrahydrocannabinol and cannabidiol at cholinergic junctions. (full – 1971)                                       http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1703324/pdf/brjpharm00552-0217.pdf

 

The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice (full – 1973)                                        http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1776598/?tool=pmcentrez&page=1

 

Intestinal obstruction by an unusual foreign body                     (full – 1973)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1946817&tool=pmcentrez

 

Psychoactive Cannabinoids Reduce Gastrointestinal Propulsion and Motility in Rodents (full – 1989)                                         http://jpet.aspetjournals.org/content/249/2/444.full.pdf+html

 

Inhibitory effect of cannabinoid agonists on gastric emptying in the rat                   (abst – 1999)

http://www.springerlink.com/content/8fe31unaaat4fbd4/

 

The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats (abst – 1999)                                         http://www.ncbi.nlm.nih.gov/pubmed/10611417

 

Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil                                                        (full – 2000)  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1572019&tool=pmcentrez

 

Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea-pig ileum (full – 2000)                                      http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1571902&tool=pmcentrez

 

Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats (abst – 2000)                                           http://www.sciencedirect.com/science/article/pii/S0014299900008438

 

Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats (abst – 2000)                                             http://www.springerlink.com/content/w3jc8rk16k9p92fl/

 

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation                                                       (full – 2001)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572987/?tool=pmcentrez

 

Cannabinoids and the gastrointestinal tract                     (full – 2001)

http://gut.bmj.com/content/48/6/859.full

 

Patent 6410588  Use of cannabinoids as anti-inflammatory agents                      (full – 2002)

http://www.patentstorm.us/patents/6410588/fulltext.html

 

Endocannabinoids as physiological regulators of colonic propulsion in mice. (abst – 2002)                                          http://www.ncbi.nlm.nih.gov/pubmed/12105851

 

 

Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon        (full – 2003)  http://ajpgi.physiology.org/content/286/1/G110.full?sid=fc6948f0-78cf-405c-981b-afaa05ee417c

 

Cannabinoids for gastrointestinal diseases: potential therapeutic applications (abst – 2003)                                      http://informahealthcare.com/doi/abs/10.1517/13543784.12.1.39

 

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.            (full – 2004)                               http://ajpgi.physiology.org/cgi/content/full/287/1/G7

 

Cannabinoids and intestinal motility: welcome to CB2 receptors                 (full – 2004)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575197/

 

Involvement of cannabinoid receptors in gut motility and visceral perception. (full – 2004)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574910/?tool=pubmed

 

Effect of ethanol extracts of three Chinese medicinal plants with laxative properties on ion transport of the rat intestinal epithelia.                                                     (full – 2004)  https://www.jstage.jst.go.jp/article/bpb/27/2/27_2_162/_pdf

 

The endogenous cannabinoid system protects against colonic inflammation

(full – 2004)            http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=385396&tool=pmcentrez

 

Cannabinoids cool the intestine               (full – 2004)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516444/?tool=pmcentrez

 

Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats                                                                  (full – 2004)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575196/?tool=pmcentrez

 

Involvement of cannabinoid receptors in gut motility and visceral perception (full – 2004)                                 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574910/?tool=pmcentrez

 

Fibromyalgia, IBS, and the Endocannabinoid-CB-Receptor (ECBR) system (abst – 2004)                                    http://www.prohealth.com//library/showArticle.cfm?libid=10562

 

Cannabinoids spell relief in colon inflammation                 (news – 2004)

http://www.medicalnewstoday.com/releases/8069.php

 

The effects of Δ9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide                                                           (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576168/?tool=pmcentrez

 

Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. (full – 2005)                                   https://www.jstage.jst.go.jp/article/jnms/72/1/72_1_43/_pdf

 

Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P                                                                    (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856307/?tool=pmcentrez

 

Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.                                               (abst – 2005)           http://www.ncbi.nlm.nih.gov/pubmed/15910887

 

Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing                                                              (abst – 2005)  http://www.gastrojournal.org/article/PIIS0016508505009297/abstract

 

Cannabis drugs may benefit those with bowel disease              (news – 2005)

http://www.news-medical.net/news/2005/08/01/12142.aspx

 

Cannabis may soothe inflamed bowels                (news – 2005)

http://www.chanvre-info.ch/info/en/Cannabis-may-soothe-inflamed.html

 

Bowel Study Backs Cannabis Drugs               (news – 2005)

http://www.thehempire.com/index.php/cannabis/news/bowel_study_backs_cannabis_drugs

 

Cannabis-Based Drugs Could Aid in Treating Bowel Disease                (news – 2005)

http://www.drugfree.org/join-together/drugs/cannabis-based-drugs-could-in

 

Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon.                                          (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1617060/?tool=pubmed

 

Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.                                                                      (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856307/?tool=pubmed

 

Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.                                                     (full – 2006)  http://www.fasebj.org/content/early/2006/03/01/fj.05-4943fje.long

 

Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P                                                                        (full – 2006)  http://gut.bmj.com/content/55/7/946.full

 

Endocannabinoid overactivity and intestinal inflammation                (full – 2006)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856409/?tool=pmcentrez

 

Endocannabinoids and the gastrointestinal tract.             (abst – 2006)

http://www.ncbi.nlm.nih.gov/pubmed/16751708?dopt=Abstract

 

Cannabinoids promote survival of normal human colonic epithelial cells (#334) (abst – 2006)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1859999/?tool=pmcentrez

 

Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study                                                          (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16918762

 

Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.        (abst – 2006)                               http://www.ncbi.nlm.nih.gov/pubmed/16506408

 

Science: Cannabinoids reduce inflammation of the bowel in animal model   (news – 2006)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=216#1

 

Synthetic THC Eases Stomach Cramping, Study Says               (news – 2006)

http://www.norml.org/index.cfm?Group_ID=7080&wtm_format=print

 

ACG: Cannabinoid Activator Mellows Out Colon             (news – 2006)

http://www.medpagetoday.com/MeetingCoverage/ACG/4410

 

Cannabis Helps Ulcers And Crohn’s Disease               (news – 2006)

http://www.thehempire.com/index.php/cannabis/news/cannabis_helps_ulcers_and_crohns_disease

 

Cannabis Drugs “May control Symptoms of Gut Disease”                (news – 2006)

http://www.bloomsburycommunications.com/presscentrepdf/bsg_22_03_06_cannabis.pdf

 

Cannabis Chemicals May Alleviate Post-Eating Stomach Cramps                (news – 2006)  http://www.bio-medicine.org/medicine-news/Cannabis-Chemicals-May-Alleviate-Post-Eating-Stomach-  Cramps-15219-1/

 

Endocannabinoids and the gastrointestinal tract: what are the key questions? (full – 2007)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190011/?tool=pmcentrez

 

Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.    (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755791/?tool=pubmed

 

The endogenous cannabinoid system: a new player in the brain-gut-adipose axis (full – 2007)       http://www.cannabis-med.org/english/journal/en_2007_02_1.pdf

 

Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study                                                     (full – 2007)  http://ajpgi.physiology.org/cgi/content/full/293/1/G137

 

Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation     (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/?tool=pmcentrez

 

Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. (abst – 2007)                                             http://www.ncbi.nlm.nih.gov/pubmed/17396241

 

The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.  (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17706636

 

Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats                                        (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494728/?tool=pubmed

 

Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.    (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/?tool=pubmed

 

Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697772/?tool=pmcentrez

 

Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice       (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2451037/?tool=pmcentrez

 

Cannabinoid CB1 Receptors Are Expressed by Parietal Cells of the Human Gastric Mucosa        (full – 2008)                           http://jhc.sagepub.com/content/56/5/511.full

 

The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet.          (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275439/?tool=pubmed

 

Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation.           (full – 2008)                             http://ajpgi.physiology.org/content/294/1/G13.long

 

Anti-inflammatory cannabinoids in diet              (full – 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633791/?tool=pmcentrez

 

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects      (abst – 2008)                          http://gut.bmj.com/content/57/8/1140.abstract

 

Cannabinoids and gastrointestinal motility: animal and human studies.              (abst – 2008)  http://www.unboundmedicine.com/medline/ebm/record/18924447/full_citation/Cannabinoids_and_gastroin testinal_motility:_animal_and_human_studies_

 

Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine          (abst – 2008)                 http://www.ncbi.nlm.nih.gov/pubmed/18671715

 

Anti-inflammatory compound from cannabis found in herbs             (news – 2008)

http://www.rsc.org/chemistryworld/News/2008/June/24060801.asp

 

Science: THC reduces reflux of acid from the stomach                (news – 2008)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=285

 

Gastrointestinal Disorders and Medical Marijuana                (full – 2008)

http://www.scribd.com/doc/294822/Medical-Marijuana-GI-brochure

 

Salutary pizza spice             (news – 2008)

http://www.eurekalert.org/pub_releases/2008-06/uob-sps062508.php

 

Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon                                                              (full – 2009)  http://ajpgi.physiology.org/cgi/content/full/296/1/G119?maxtoshow=&hits=80&RESULTFORMAT=&full text=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT

 

Interaction between cannabinoid CB1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum.                                                        (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795265/?tool=pubmed

 

Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids. (full – 2009)                                           http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739820/?tool=pubmed

 

Endocannabinoids and the gastrointestinal tract: what are the key questions?

(full – 2009)                http://www3.interscience.wiley.com/cgi-bin/fulltext/121667871/HTMLSTART

 

Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception          (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765124/?tool=pubmed

 

Cannabinoids as novel anti-inflammatory drugs.              (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/?tool=pubmed

 

Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration.                                                                      (abst – 2009)  http://www.ncbi.nlm.nih.gov/pubmed/19827302

 

Cannabinoids in intestinal inflammation and cancer.              (abst – 2009)  http://www.ncbi.nlm.nih.gov/pubmed/19442536?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPa   nel.Pubmed_RVDocSum&ordinalpos=22

 

Medical Marijuana and Gastritis                (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/161?ailment=gastritis

 

Cannabis for Ulcerative Colitis and Crohn’s Disease treatment               (news – 2009)  http://www.news-medical.net/news/20091217/Cannabis-for-Ulcerative-Colitis-and-Crohns-Disease-  treatment.aspx

 

Medical Marijuana and Diverticulitis                 (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/107?ailment=diverticulitis

 

Gastrointestinal Disorders                    (news – 2009)

http://www.norml.org/index.cfm?Group_ID=7009

 

Medical Marijuana and Constipation                 (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/108?ailment=constipation

 

The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn’s Disease                                                        (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829088/?tool=pmcentrez

 

The endocannabinoid system links gut microbiota to adipogenesis              (full – 2010)

http://www.nature.com/msb/journal/v6/n1/full/msb201046.html

 

Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus. (full – 2010)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2009.01419.x/pdf

 

US Patent Application 20100222437 – COMPOSITION CONTAINING NON- PSYCHOTROPIC CANNABINOIDS FOR THE TREATMENT OF INFLAMMATORY DISEASES        (full – 2010)

http://www.patentstorm.us/applications/20100222437/fulltext.html

 

Cannabinoids and the gut: New developments and emerging concepts.           (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20117132

 

Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability.        (abst – 2010)                          http://www.ncbi.nlm.nih.gov/pubmed/20592049

 

Gut feelings about the endocannabinoid system              (full – 2011)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full

 

Treatment of Crohn’s disease with cannabis: an observational study.               (full – 2011)

http://www.ima.org.il/IMAJ/ViewArticle.aspx?year=2011&month=08&page=455

 

Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full – 2011)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed

 

Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation.   (full – 2011)  http://www.nature.com/ajg/journal/v106/n1/pdf/ajg2010305a.pdf

 

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

 

Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.       (full – 2011)                                        http://www.fasebj.org/content/25/8/2711.long

 

A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.        (abst – 2011)                      http://www.ncbi.nlm.nih.gov/pubmed/21726355

 

Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.                                      (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21726418

 

Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.  (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21876860

 

The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus.                                                        (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21975813/abstract/The_effects_of_cannabidiolic_a   cid_and_cannabidiol_on_contractility_of_the_gastrointestinal_tract_of_Suncus_murinus_

 

ENDOGENOUS CANNABINOID SYSTEM REGULATES INTESTINAL BARRIER FUNCTION IN VIVO THROUGH CANNABINOID TYPE 1 RECEPTOR ACTIVATION       (abst – 2011)

http://ajpgi.physiology.org/content/early/2011/11/28/ajpgi.00158.2011.abstract?sid=d420a7ad       -54ba-4946-  b1da-8bfe664eeec2

 

Effects of Cannabinoid Agonists on Sheep Sphincter of Oddi in vitro.            (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21921665

 

Inhibition of cannabinoid metabolic enzymes reduces NSAID-induced gastric pathology (abst – 2011)  http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/807.1?maxtoshow=&hits=80&  RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype

=HWCIT

 

Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. (abst – 2011)                                    http://www.ncbi.nlm.nih.gov/pubmed/21745190

 

Surgery REVERSED by Cannabis Oil from vaporizer!               (anecdotal – 2011)

http://medicalmarijuana411.com/mmj411_v3/?p=10687

 

“THC Oil Is Saving The Life of My Sister”                 (anecdotal – 2011)

http://medicalmarijuana411.com/mmj411_v3/?p=10599

 

The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility.             (full – 2012)

http://content.karger.com/produktedb/produkte.asp?DOI=000339072&typ=pdf

 

The JNK inhibitor XG-102 protects against TNBS-induced colitis.  (full – 2012)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302790/

 

Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.                                                        (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22300105

 

Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis.                                          (abst – 2012)         http://www.ncbi.nlm.nih.gov/pubmed/22269477

 

 

Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome. (abst – 2012)                                        http://www.ncbi.nlm.nih.gov/pubmed/22403795

 

The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention. (abst – 2012)                                     http://www.sciencedirect.com/science/article/pii/S1043661812000540

 

Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice                                                                (abst – 2012)  http://www.jleukbio.org/content/91/6/911.abstract?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=  cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT

 

Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice.  (abst – 2012)                                                 http://www.ncbi.nlm.nih.gov/pubmed/22759743

 

The effects of fasting duration on gastric emptying in man, an exploration of the role of the endocannabinoid system and inter-individual responsiveness                                                   (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01954.x/abstract

 

Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility.                                                          (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22836266

 

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                                                     (abst – 2012)      http://www.ncbi.nlm.nih.gov/pubmed/22917662

 

A potential role for GPR55 in gastrointestinal functions.             (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/23063456

 

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                                                     (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22917662?dopt=Abstract

 

Endocannabinoid modulation of jejunal afferent responses to LPS               (abst – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01961.x/abstract

 

Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.                                                                   (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/21883147

 

Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis.                                     (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23285225

 

Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects.

(abst – 2013)                http://www.ncbi.nlm.nih.gov/pubmed/23412396

 

 

Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits.           (abst – 2013)                                            http://www.ncbi.nlm.nih.gov/pubmed/23306084

Share a link for

1 Comment

  1. I couldn’t refrain from commenting. Exceptionally well written!

Leave a Reply

Your email address will not be published.

*

© 2019 Debbie's Place

Powered by

www.420.ag